Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.87 | N/A |
| PEG Ratio (TTM) | 0.29 | N/A |
| P/S Ratio (TTM) | 1.11 | N/A |
| P/B Ratio (TTM) | 1.50 | N/A |
| P/FCF Ratio (TTM) | 8.65 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.46 | N/A |
| Price to 5YR AVG FCF Ratio | 12.21 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.34% | N/A |
| ROE (TTM) | 5.62% | N/A |
| Net Profit Margin (TTM) | 4.13% | N/A |
| ROIC 5YR AVG | 7.61% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.41% | 12.31% | -6.94% |
| Revenue | 0.21% | 6.74% | 4.96% |
| Net Income | -33.19% | 15.61% | -5.08% |
| Cash Flow | 18.11% | 7.86% | 22.12% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.70 | N/A |
| Quick Ratio (TTM) | 0.22 | N/A |
| D/E Ratio (TTM) | 0.25 | N/A |
| Interest Coverage (TTM) | 15.20 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.73 | N/A |
| LTL to 5YR AVG FCF | 7.09 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.59% | N/A |